fentanyl and nalmefene

fentanyl has been researched along with nalmefene in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19902 (13.33)18.7374
1990's4 (26.67)18.2507
2000's6 (40.00)29.6817
2010's1 (6.67)24.3611
2020's2 (13.33)2.80

Authors

AuthorsStudies
Adapa, ID; Auh, JS; Berzetei-Gurske, IP; Brandt, SR; Craymer, K; Farrington, L; Haggart, D; Kennedy, JM; O'Brien, A; Polgar, WE; Rodriguez, L; Schwartz, RW; Toll, L; White, A1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
DiFazio, CA; Dixon, R; Gal, TJ1
DiFazio, CA; Gal, TJ1
Osifchin, E; Veng-Pedersen, P; Waters, SJ; Wilhelm, JA; Zakszewski, TB2
Civelek, AC; Dannals, RF; Dixon, RB; Joh, T; Kao, PF; Kim, S; Ravert, HT; Villemagne, VL; Wagner, HN1
Dougherty, TB; Porche, VH; Thall, PF1
Burns, MM; Chumpa, A; Kaplan, RL; Shannon, MW1
Aalto, S; Hagelberg, N; Hietala, J; Ingman, K; Juhakoski, A; Kallio, A; Karhuvaara, S; NĂ¥gren, K; Oikonen, V; Scheinin, H1
Dong, H; Gao, X; Gong, Z; Ma, W; Su, R; Yong, Z1
Chen, Y; Fu, C; Hu, R; Huang, C; Jiang, H; Li, C; Sun, Y; Tang, D; Wang, H; Yan, J; Zhu, J1
Cao, H; Dai, F; Liu, Y; Lu, H; Shan, G; Yin, D1

Trials

7 trial(s) available for fentanyl and nalmefene

ArticleYear
Prolonged blockade of opioid effect with oral nalmefene.
    Clinical pharmacology and therapeutics, 1986, Volume: 40, Issue:5

    Topics: Administration, Oral; Adult; Analgesia; Clinical Trials as Topic; Double-Blind Method; Fentanyl; Humans; Male; Naltrexone; Narcotic Antagonists; Respiration; Time Factors

1986
Prolonged antagonism of opioid action with intravenous nalmefene in man.
    Anesthesiology, 1986, Volume: 64, Issue:2

    Topics: Adult; Drug Interactions; Fentanyl; Humans; Male; Muscle Rigidity; Naltrexone; Pain; Respiration; Tidal Volume; Time Factors

1986
Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual-detector system.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997, Volume: 38, Issue:11

    Topics: Adult; Analgesics, Opioid; Brain; Carbon Radioisotopes; Cross-Over Studies; Female; Fentanyl; Humans; Male; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid; Time Factors; Tomography, Emission-Computed

1997
Maximum tolerated dose of nalmefene in patients receiving epidural fentanyl and dilute bupivacaine for postoperative analgesia.
    Anesthesiology, 2000, Volume: 92, Issue:4

    Topics: Adult; Aged; Analgesia, Epidural; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Female; Fentanyl; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Pain, Postoperative

2000
Nalmefene for elective reversal of procedural sedation in children.
    The American journal of emergency medicine, 2001, Volume: 19, Issue:7

    Topics: Analgesics, Opioid; Anesthetics, Intravenous; Antidotes; Child; Child, Preschool; Emergency Medical Services; Female; Fentanyl; Humans; Infant; Male; Midazolam; Naltrexone; Narcotic Antagonists

2001
Prolonged central mu-opioid receptor occupancy after single and repeated nalmefene dosing.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2005, Volume: 30, Issue:12

    Topics: Adolescent; Adult; Analgesics, Opioid; Area Under Curve; Caudate Nucleus; Electrocardiography; Fentanyl; Glucuronides; Humans; Male; Naltrexone; Narcotic Antagonists; Positron-Emission Tomography; Prefrontal Cortex; Receptors, Opioid, mu; Thalamus

2005
Low-dose nalmefene pretreatment reduces etomidate-induced myoclonus: A randomized, double-blind controlled trial.
    Medicine, 2023, Sep-08, Volume: 102, Issue:36

    Topics: Anesthesia, General; Cough; Drug-Related Side Effects and Adverse Reactions; Etomidate; Fentanyl; Humans; Myoclonus; Saline Solution

2023

Other Studies

8 other study(ies) available for fentanyl and nalmefene

ArticleYear
Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications.
    NIDA research monograph, 1998, Volume: 178

    Topics: Animals; Aorta, Thoracic; Cocaine; Cyclic AMP; Electric Stimulation; Guinea Pigs; Humans; Ileum; In Vitro Techniques; Male; Mice; Muscle, Smooth; Opioid-Related Disorders; Rats; Receptors, Dopamine; Receptors, Opioid; Receptors, Serotonin; Substance-Related Disorders

1998
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Duration of opioid antagonism by nalmefene and naloxone in the dog: an integrated pharmacokinetic/pharmacodynamic comparison.
    Journal of pharmaceutical sciences, 1995, Volume: 84, Issue:9

    Topics: Animals; Blood Gas Monitoring, Transcutaneous; Dogs; Female; Fentanyl; Infusions, Intravenous; Models, Biological; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Respiration

1995
Duration of opioid antagonism by nalmefene and naloxone in the dog. A nonparametric pharmacodynamic comparison based on generalized cross-validated spline estimation.
    International journal of clinical pharmacology and therapeutics, 1995, Volume: 33, Issue:10

    Topics: Analysis of Variance; Animals; Carbon Dioxide; Computer Simulation; Cross-Over Studies; Dogs; Drug Tolerance; Fentanyl; Injections, Intravenous; Male; Models, Statistical; Naloxone; Naltrexone; Narcotic Antagonists; Respiratory Insufficiency; Time Factors

1995
Nalmefene reverses carfentanil-induced loss of righting reflex and respiratory depression in rats.
    European journal of pharmacology, 2014, Sep-05, Volume: 738

    Topics: Analgesics, Opioid; Animals; Blood Gas Analysis; Dose-Response Relationship, Drug; Fentanyl; Male; Naltrexone; Rats; Rats, Sprague-Dawley; Reflex, Righting; Respiratory Insufficiency; Time Factors

2014
GluN2A-selective positive allosteric modulator-nalmefene-flumazenil reverses ketamine-fentanyl-dexmedetomidine-induced anesthesia and analgesia in rats.
    Scientific reports, 2020, 03-24, Volume: 10, Issue:1

    Topics: Adjuvants, Anesthesia; Allosteric Regulation; Analgesia; Anesthesia; Animals; Delayed Emergence from Anesthesia; Dexmedetomidine; Drug Combinations; Drug Evaluation, Preclinical; Female; Fentanyl; Flumazenil; GABA-A Receptor Antagonists; Ketamine; Male; Maze Learning; Naltrexone; Narcotic Antagonists; Nociception; Pain Measurement; Rats; Receptors, N-Methyl-D-Aspartate; Reflex, Righting; Rotarod Performance Test

2020